Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Mol Cancer Res. 2014 Mar 11;12(6):912–923. doi: 10.1158/1541-7786.MCR-13-0620-T

Table 1. CDKN2AB status of KRAS mutant non-small cell lung cancer cell lines.

CDKN2AB mutation status is indicated as WT – wild type, HOMO – homozygous loss, HET – heterozygous loss, MUT – KRAS mutation. Pathologic classification of cell lines is indicated as it was given at the time the cell lines were raised.

Cell Line Tumor Subtype CDKN2AB Status KRAS
A549 Adenocarcinoma HOMO MUT
H460 Large Cell HOMO MUT
H1944 Adenocarcinoma HOMO MUT
HCC1171 NSCLC HOMO MUT
HCC4017 Large Cell HOMO MUT
HOP-62 Adenocarcinoma HOMO MUT
H23 Adenocarcinoma HET MUT
H157 Squamous HET MUT
H358 Adenocarcinoma HET MUT
H441 Adenocarcinoma HET MUT
H1355 Adenocarcinoma HET MUT
H1373 Adenocarcinoma HET MUT
H1734 Adenocarcinoma HET MUT
H2009 Adenocarcinoma HET MUT
H2122 Adenocarcinoma HET MUT
H2347 Adenocarcinoma HET MUT
H2887 NSCLC HET MUT
HCC366 Adenosquamous HET MUT
HCC461 Adenocarcinoma HET MUT
HCC515 Adenocarcinoma HET MUT
Calu-6 Adenocarcinoma HET MUT
H1155 Large Cell WT MUT
HCC44 Adenocarcinoma WT MUT